Previous Close | 20.93 |
Open | 21.00 |
Bid | 20.64 x 100 |
Ask | 20.77 x 100 |
Day's Range | 20.49 - 21.05 |
52 Week Range | 18.69 - 55.89 |
Volume | |
Avg. Volume | 433,598 |
Market Cap | 1.113B |
Beta (5Y Monthly) | 0.18 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.94 |
Earnings Date | Nov 04, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 61.43 |
DUBLIN, August 29, 2024--Prothena today announced that members of its senior management team will participate in two upcoming investor conferences in September 2024.
Prothena (PRTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
We recently compiled a list of the 7 Best Debt Free Stocks To Buy. In this article, we are going to take a look at where Prothena Corporation plc (NASDAQ:PRTA) stands against the other debt free stocks. Debt has always been the fuel driving many companies in the equity markets. Access to cheap capital when […]